HOVIONE FARMACIENCIA S.A.

Company Profile: HOVIONE FARMACIENCIA S.A.

Headquarters: Portugal

Global Business: Hovione Farmaciencia S.A. is a global company that specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and drug product intermediates. They operate as a Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry, providing services from early-stage development to commercial manufacturing.

Presence in India: Based on current public information, Hovione Farmaciencia S.A. does not operate a manufacturing plant directly under its name in India. Their primary manufacturing facilities are located in Portugal, the United States, Ireland, and China.

Factory or Trader in India: In the context of India, Hovione Farmaciencia S.A. would primarily function as a commercial entity, engaging in sales, marketing, or business development activities for its globally manufactured products, rather than operating as a manufacturing factory within India itself. Globally, they are a manufacturer.

Hovione Farmaciencia S.A. is a Contract Development and Manufacturing Organization (CDMO) that specializes in the production of Active Pharmaceutical Ingredients (APIs) and drug product intermediates for other pharmaceutical companies globally. While Hovione does not have manufacturing facilities in India, it supplies its products to pharmaceutical companies worldwide, including potentially those operating in India, through its global supply chain.

The products Hovione produces and sells are primarily Active Pharmaceutical Ingredients (APIs) and intermediates for a wide range of therapeutic areas. These include, but are not limited to: APIs for respiratory diseases such as inhaled corticosteroids and bronchodilators; APIs for oncology treatments; APIs for ophthalmic applications; Highly Potent Active Pharmaceutical Ingredients (HPAPIs); APIs with tailored particle engineering properties, such as those produced via spray drying or micronization technologies; and custom-synthesized APIs and intermediates developed under contract for specific clients.